title: Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein.
abstract: Macroautophagy is an essential degradative pathway that can be induced to clear aggregated proteins, such as those found in Parkinson's disease and dementia with Lewy bodies, a form of Parkinsonism. This study found that both LC3-II and beclin were significantly increased in brains from humans with Dementia with Lewy bodies and transgenic mice overexpressing mutant alpha-synuclein, as compared with respective controls, suggesting that macroautophagy is induced to remove alpha-syn, particularly oligomeric or mutant forms. Aged mutant animals had higher autophagy biomarker levels relative to younger animals, suggesting that with aging, autophagy is less efficient and requires more stimulation to achieve the same outcome. Disruption of autophagy by RNA interference significantly increased alpha-syn oligomer accumulation in vitro, confirming the significance of autophagy in alpha-syn clearance. Finally, rotenone-induced alpha-syn aggregates were cleared following rapamycin stimulation of autophagy. Chronic rotenone exposure and commensurate reduction of metabolic activity limited the efficacy of rapamycin to promote autophagy, suggesting that cellular metabolism is critical for determining autophagic activity. Cumulatively, these findings support the concept that neuronal autophagy is essential for protein homeostasis and, in our system, reduction of autophagy increased the accumulation of potentially pathogenic alpha-synuclein oligomers. Aging and metabolic state were identified as important determinants of autophagic activity. This study provides therapeutic and pathological implications for both synucleinopathy and Parkinson's disease, identifying conditions in which autophagy may be insufficient to degrade alpha-syn aggregates.
authors.affiliation: Dept of Pathology, Columbia University Medical Center, 630 W168th St Rm 12-461, New York NY 10032, USA.
authors.forename: Wai Haung
authors.initials: WH
authors.lastname: Yu
authors.forename: Beatriz
authors.initials: B
authors.lastname: Dorado
authors.forename: Helen Yvette
authors.initials: HY
authors.lastname: Figueroa
authors.forename: Lili
authors.initials: L
authors.lastname: Wang
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Planel
authors.forename: Mark R
authors.initials: MR
authors.lastname: Cookson
authors.forename: Lorraine N
authors.initials: LN
authors.lastname: Clark
authors.forename: Karen E
authors.initials: KE
authors.lastname: Duff
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001343:Autophagy / Q000235:genetics; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology; D051844:alpha-Synuclein / Q000235:genetics / Q000378:metabolism*
chemical_list: D051844:alpha-Synuclein